Related Experiment Video
Updated: Jun 19, 2026
10:57
Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
Published on: July 13, 2015
Knowledge about antipsychotic long-acting injections: bridging that gap
The British Journal of Psychiatry. Supplement
|November 3, 2009
Summary
Long-acting injectable antipsychotics (LAIs) are crucial for treating psychosis, yet require more research. This review highlights dosing variations and the need for specific guidelines to optimize LAI use in clinical practice.
Area of Science:
- Psychiatry and Pharmacology
- Clinical Practice Guidelines
- Evidence-Based Medicine
Background:
- Long-acting injectable antipsychotics (LAIs) are essential in managing long-term psychosis, particularly for patients with adherence challenges.
- Despite their significance, LAIs remain underresearched, with notable variations in dosing strategies and a lack of standardized clinical guidelines.
- The use of LAIs experienced a temporary decline with the advent of oral atypical antipsychotics but is now re-emerging as a central treatment modality.
Discussion:
- Traditional systematic reviews are insufficient for evaluating LAIs due to their unique clinical application.
- This supplement effectively integrates experimental and observational research to provide a comprehensive overview of LAI utilization.
- The findings underscore the critical need for further research to establish evidence-based guidelines for LAI therapy.
Key Insights:
- LAIs play a significant role in current psychiatric practice, especially for chronic psychosis management.
- Significant variability exists in LAI dosing protocols, indicating a gap in established treatment guidelines.
- A combined approach of experimental and observational studies is valuable for understanding LAI efficacy and application.
Outlook:
- Future research should focus on developing specific, evidence-based guidelines for LAI selection and administration.
- Optimizing LAI use can improve treatment adherence and outcomes for patients with long-term psychosis.
- LAIs are poised to regain and maintain a central position in the therapeutic landscape for psychosis management.
Related Concept Videos
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...